ADIPOQ and Insulin resistance: As referred, aging is known to be associated with increasing insulin resistance, weight, and adiposity gain.    According to our data, aging in T2DM patients is associated with an altered adipokine secretion, as shown by the significant and positive correlations with leptin and chemerin and the inverse correlation with adiponectin.